Contagion, February 2023 (Vol. 08, No. 1)

"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "

"We made a mistake," said Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP. "We needed to have a 3-dose primary series and not call these booster shots.”

Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.

Carbapenem-resistant Enterobacterales present considerable treatment challenges. Recent cumulative evidence supports preference for therapies.

Inequities can include access to care issues that run from prevention to acute treatment. Addressing such issues can lead to better outcomes.

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.

Although fecal microbiota, live-jslm (Rebyota; RBX2660) is the first fecal microbiota product approved by the FDA, there are other microbiota-based agents in the pipeline.

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).

This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.

As COVID-19 evolves, learning how to live with a virus that has become endemic will have its challenges, but medical science will help the public be able to accept it.

Although HIV remains a pervasive epidemic, there have been tremendous advancements and progress in HIV prevention, and the work continues.